NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Ecolab Closes In on $5 Billion Deal for KKR's AI Cooling Star CoolIT

Ecolab nears $4.5–5B acquisition of CoolIT Systems from KKR, riding AI-driven demand for advanced data-center liquid cooling—up massively from 2023's $270M valuation.

Ecolab Closes In on $5 Billion Deal for KKR's AI Cooling Star CoolIT
Credit: coolitsystems.com
Already have an account? Sign in.
03/19/2026 · 1:56 PM
ECL
/ Read more

Feed↓

Roche Abandons Emugrobart – Clears Path for Scholar Rock’s Apitegromab to Dominate SMA
Featured/ 03/19/2026 · 3:28 PM

Roche Abandons Emugrobart – Clears Path for Scholar Rock’s Apitegromab to Dominate SMA

Roche halts emugrobart development, clearing path for Scholar Rock's apitegromab to dominate SMA muscle therapy market. Cantor sees multi-billion potential.

/ Subscriber only
20% of Global LNG Offline – Iran's Missile Barrage Hits Qatar's Energy Heart
Featured/ 03/19/2026 · 1:12 PM

20% of Global LNG Offline – Iran's Missile Barrage Hits Qatar's Energy Heart

Iran's missile strikes cause extensive damage to Qatar's Ras Laffan LNG hub (20% of world supply). Prices soar, Europe & Asia brace for shortages through 2026.

/ Subscriber only
Lilly’s Retatrutide Crushes Weight Loss Goals in First Phase 3 Trial – Wall Street Says It’s a ‘Key Pillar’ for Growth
Featured/ 03/19/2026 · 12:51 PM

Lilly’s Retatrutide Crushes Weight Loss Goals in First Phase 3 Trial – Wall Street Says It’s a ‘Key Pillar’ for Growth

Eli Lilly’s retatrutide delivered up to 2.0% A1C reduction and 16.8% weight loss (36.6 lbs) in its first Phase 3 trial for type 2 diabetes. Analysts call it a key growth driver for Lilly with strong results vs Mounjaro.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe